CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial
Authors
An Sileghem
Anne Durnez
+48 more
Bert Vander Cruyssen
C Deighton
C Grigor
Christine Langenaken
CM Spies
D Aletaha
D Aletaha
D Cock De
D Cock De
D Porter
Diederik De Cock
Elke Geens
Els Van Essche
F Buttgereit
F Buttgereit
FC Arnett
Frank Raeman
G Sakellariou
Griet De Brabanter
Isabelle Ravelingien
JA Singh
Jan Lenaerts
Jan Remans
Johan Joly
Johan Vanhoof
JS Smolen
Klaas Vandevyvere
Kristien Van der Elst
KV Wevers-de Boer
L Barra
Luk Corluy
M Boers
MF Bakker
N Duru
P Verschueren
P Verschueren
Patrick Verschueren
Piet Geusens
Rene Westhovens
Rik Joos
S Ajeganova
S Meyfroidt
S Meyfroidt
Sabrina Meyfroidt
SL Gorter
T Möttönen
Veerle Taelman
YP Goekoop-Ruiterman
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs13075-015-...
Last time updated on 01/04/2019